Does a hybrid iFR-FFR decision-making strategy reduce the need for vasodilator administration compared to an FFR-only strategy in patients undergoing coronary revascularisation?
A hybrid iFR-FFR strategy may facilitate broader adoption of physiology-guided PCI by reducing the need for vasodilators without compromising diagnostic accuracy.
A hybrid iFR-FFR decision-making strategy for revascularisation could increase adoption of physiology-guided PCI, by more than halving the need for vasodilator administration, whilst maintaining high classification agreement with an FFR-only strategy.
Petraco et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: